Carolyn M. Rucci
CIK: 0002107264
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Akebia Therapeutics, Inc.
Discretionary Trading P&L
Holdings
Transaction History (4 total)
- Feb 2, 2026AKBA
Akebia Therapeutics, Inc.
Sale(S)Direct16.8K shares at avg. $1.39$23K - Feb 2, 2026AKBA
Akebia Therapeutics, Inc.
Sale(S)Direct25.4K shares at avg. $1.39$35K - Feb 2, 2026AKBA
Akebia Therapeutics, Inc.
Sale(S)Direct27.5K shares at avg. $1.39$38K - Jan 30, 2026AKBA
Akebia Therapeutics, Inc.
Award(A)Direct190K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Feb 2, 2026 | AKBA Akebia Therapeutics, Inc. | Sale(S) | 16,846 | $1.39 | $23,416 | Direct |
| Feb 2, 2026 | AKBA Akebia Therapeutics, Inc. | Sale(S) | 25,382 | $1.39 | $35,281 | Direct |
| Feb 2, 2026 | AKBA Akebia Therapeutics, Inc. | Sale(S) | 27,544 | $1.39 | $38,286 | Direct |
| Jan 30, 2026 | AKBA Akebia Therapeutics, Inc. | Award(A) | 190,000 | - | $0 | Direct |
1-4 of 4 transactions
About Rucci Carolyn M.
Rucci Carolyn M. (SEC CIK 0002107264) files insider reports with the SEC as SVP, Chief Legal Officer of Akebia Therapeutics, Inc. (AKBA).
Signal8 holds 3 ownership filings by Rucci Carolyn M. (1 Form 3, 2 Form 4), filed between Feb 3, 2026 and Feb 4, 2026. Those filings report 4 transactions, from Jan 30, 2026 to Feb 2, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Rucci Carolyn M.'s filings is in CAMBRIDGE, MA.
Recent filings by Rucci Carolyn M.
Other insiders filing for Akebia Therapeutics, Inc. (AKBA)
- Butler John P., CEO and President
- Ostrowski Erik, SVP, CFO, CBO & Treasurer
- Wolf Myles, Director
- Smith Cynthia, Director
- ROGERS MICHAEL W, Director
- FRIESON RON, Director